President Joko “Jokowi” Widodo said government targets to produce COVID-19 vaccines on the first half (H1) of 2021. The state-owned drug maker, PT Biofarma joined with Chinese’ Sinovac and other stakeholders now in the process to create the new medicines and has been tested for third time.
“For three months we developed our own vaccine with brand Merah Putih. It is estimated that this can be completed in mid-2021 by various parties and open themselves to collaborating with SINOVAC, Uni Arab Emirates, South Korea and others to be able to vaccinate all Indonesian people,” Jokowi told reporters during his official visit to West Java province on Tuesday (11/8).
On July 21, a total of 2,400 vaccines from Sinovac have arrived at Bio Farma. According to the CEO, Honesti Basyir, the clinical trial of the vaccine is scheduled to run for six months, so it is targeted to be completed in January 2021.
